ArticleJournal of thoracic disease2026
Global trends and research hotspots in enhanced recovery after surgery (ERAS) for lung cancer resection: a bibliometric and visual analysis (2010-2025).
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enhanced recovery after surgery (ERAS) protocols have revolutionized perioperative care in lung cancer resection, significantly improving postoperative outcomes. However, a comprehensive analysis of the global research trends, intellectual structure, and evolving hotspots in this specific domain over the past 15 years remains lacking. This study aims to bridge this gap by conducting a comprehensive bibliometric and visual analysis of literature from 2010 to 2025. Methods: Literature regarding ERAS in lung cancer surgery published from 2010 to 2025 was retrieved from the Web of Science Core Collection (WoSCC). Bibliometric analyses were conducted using VOSviewer, CiteSpace, and R-bibliometrix to visualize spatial distributions, collaboration networks, co-citation structures, and keyword trends. Results: A total of 472 eligible publications were identified, exhibiting an exponential growth trajectory particularly after 2018. China emerged as the leading contributor with 137 documents, followed by the United States with 107 publications, while European nations demonstrated exceptional citation impact. The University of Copenhagen and its affiliated hospitals formed the dominant institutional cluster, and the Journal of Thoracic Disease served as the primary publishing venue. Analysis of citation bursts and keyword evolution revealed a paradigm shift in research focus. The field evolved from initial feasibility studies involving lung resection to protocol standardization and safety. Most recently, the emphasis has shifted towards patient-centered outcomes represented by quality-of-life (QoL) assessments and precision minimally invasive techniques. Conclusions: Research on ERAS for lung cancer is rapidly expanding and has matured from establishing safety to refining comprehensive care. The current trend emphasizes the integration of precision surgery with patient-centered QoL assessments. This study provides a global roadmap for researchers to identify key collaborators and emerging frontiers in thoracic oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.